Translate Bio: Sanofi to Buy Translate Bio, For $3.2 Billion

Sanofi (Stock: SAN) is to acquire Translate Bio (NASDAQ: TBIO), a Lexington, MA-based clinical-stage mRNA therapeutics company. Sanofi will acquire all outstanding shares of Translate Bio for $38.00 per share in cash, which represents a total equity value of approximately $3.2 billion (on a fully diluted basis). The acquisition wil enable Sanofi to accelerate the application [...]The post Sanofi to Buy Translate Bio, For $3.2 Billion appeared first on FinSMEs.